The Revision of Class III Medical Devices that Need to be Approved for Clinical Trial ( revised in 2020)

2020, September 14th, in order to further strengthening the management of medical instruments clinical trial in the process of maintenance of medical instrument clinical trial subjects rights and interests, promote the regulation of scientific research achievements, improve the efficiency of examination and approval, and to speed up the market, the NMPA organized the revision of the opinions on 'deepening the Reform of the Review and Approval System to Encourage innovation of Drugs and Medical Devices'. According to 'the regulations on the supervision and administration of medical devices', the NMPA organized the revision of the list of category III medical devices subject to clinical trial approval, which is hereby promulgated and shall come into force as of the date of promulgation.

The circular on the publication of the Catalogue of Category III Medical Devices subject to Clinical Trial Approval (CFDA circular No. 14 of 2014) shall be repealed simultaneously.

Contact Us
CIRS China

Mr. Harold Xie (Head office)
Tel: +86-571 8720 6559 | Fax: +86-571 87206533
Email: md@cirs-group.com
Mr. Edwin Wen (Beijing office)
Tel: +86-10 63984062 | Fax: +86-10 63984032
Email: md@cirs-group.com

CIRS Europe

Bryan Zhou
Tel:  +353 (1)477 3710

Email: md@cirs-group.com

CIRS Korea
Mr. Junho Lee 
Tel: +82 2 6347 8801 
Email: md@cirs-group.com